Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Saudi Medical Journal. 2006; 27 (2): 198-204
em Inglês | IMEMR | ID: emr-80684

RESUMO

To study the changes in the epidemiology, clinical and bacteriological profiles of bacterial meningitis in the era of the Haemophilus influenzae type b [Hib]vaccine and pneumococcus resistance. This is a retrospective study of children aged <12 years admitted to the Hamad Medical Corporation, Qatar between January 1998 through December 2002 with positive cerebrospinal fluid culture. We described 64 patients with culture proven bacterial meningitis. In infants <3 months [n=29 [45%]], the most common organism was Group B Streptococcus [GBS] [20%]. Children >3 months [n=35 [55%]]; Hib [25%] and Streptococcus pneumoniae [STP] [20%] were the most common organisms before introduction of Hib vaccination. A significant drop of Hib infections were noticed after introduction of the vaccine. Fever, neck stiffness, seizure, vomiting, and bulging fontanel were the most frequent presenting features. Group B Streptococcus were sensitive to ampicillin and cefotaxime with no resistance detected. Forty percent of STP isolates were resistant to penicillin and 12% were resistant to ceftriaxone. Fifty percent of Hib were resistant to ampicillin; while none of Hib were resistant to ceftriaxone. No case of Listeria monocytogenes meningitis was diagnosed. Morbidity was 28%, and one patient expired [2%] after Klebsiella pneumoniae meningitis. Streptococcus pneumoniae was associated with the highest morbidity [62%] while Hib had zero morbidity in our patients. Bacterial meningitis is a serious illness with a significant morbidity and mortality. Haemophilus influenzae type b infection decreased which indicated an effective vaccination. As there is 12% bacterial resistance of STP reported against ceftriaxone; We recommend Cefotaxime for infants <3 months while ceftriaxone plus vancomycin as empiric therapy for older patients with community acquired bacterial meningitis. A pneumococcal vaccination may further decrease the incidence of meningitis in our community. A continuos surveillance to detect changes in the microbiology of organisms causing bacterial meningitis or their sensitivity in our community is essential to update these recommendations


Assuntos
Humanos , Masculino , Feminino , Infecções Estreptocócicas/epidemiologia , Infecções por Haemophilus/epidemiologia , Estudos Retrospectivos , Doença Aguda
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA